Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma
2024 · Molecular Cell · 56 citations
https://doi.org/10.1016/j.molcel.2023.12.003
D
Damon A. Hofman
Oncode Institute(NL)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
210
Citations
7
h-index
6
i10-index
Damon A. Hofman is an academic researcher from Oncode Institute. The author has contributed to research in topics: Immunotherapy and Immune Responses & Monoclonal and Polyclonal Antibodies Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 7, co-authored 46 publications.
ORCID: 0000-0003-4411-4563Papers by this author
worksMicroproteins in cancer: identification, biological functions, and clinical implications
2024 · Trends in Genetics · 31 citations
https://doi.org/10.1016/j.tig.2024.09.002
Figure S7 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2024 · 0 citations
https://doi.org/10.1158/2326-6066.25964331.v1
Figure S16 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2024 · 0 citations
https://doi.org/10.1158/2326-6066.25964352.v1
Figure S8 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2024 · 0 citations
https://doi.org/10.1158/2326-6066.25964328.v1
Figure S11 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2024 · 0 citations
https://doi.org/10.1158/2326-6066.25964370.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat